These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2478490)

  • 21. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
    Bolhuis RL; Roozemond RC; van de Griend RJ
    J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity.
    Galandrini R; Albi N; Zarcone D; Grossi CE; Velardi A
    Eur J Immunol; 1992 Aug; 22(8):2047-53. PubMed ID: 1379184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production of granulocyte/macrophage-colony-stimulating factor by human natural killer cells. Modulation by the p75 subunit of the interleukin 2 receptor and by the CD2 receptor.
    Levitt LJ; Nagler A; Lee F; Abrams J; Shatsky M; Thompson D
    J Clin Invest; 1991 Jul; 88(1):67-75. PubMed ID: 1676038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD2 is functionally linked to the zeta-natural killer receptor complex.
    Vivier E; Morin PM; O'Brien C; Schlossman SF; Anderson P
    Eur J Immunol; 1991 Apr; 21(4):1077-80. PubMed ID: 1673433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Signal transduction by the CD2 antigen in T cells and natural killer cells: requirement for expression of a functional T cell receptor or binding of antibody Fc to the Fc receptor, Fc gamma RIIIA (CD16).
    Spruyt LL; Glennie MJ; Beyers AD; Williams AF
    J Exp Med; 1991 Dec; 174(6):1407-15. PubMed ID: 1683892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD16 surface molecules regulate the cytolytic function of CD3CD16+ human natural killer cells.
    Moretta A; Tambussi G; Ciccone E; Pende D; Melioli G; Moretta L
    Int J Cancer; 1989 Oct; 44(4):727-30. PubMed ID: 2793244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for the involvement of CD56 molecules in alloantigen-specific recognition by human natural killer cells.
    Suzuki N; Suzuki T; Engleman EG
    J Exp Med; 1991 Jun; 173(6):1451-61. PubMed ID: 1709676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphocyte leukocyte function-associated antigen 1 interacting with target cell intercellular adhesion molecule 1 co-activates cytolysis triggered via CD16 or the receptor involved in major histocompatibility antigen-unrestricted lysis.
    Goedegebuure PS; Braakman E; Segal DM; Vreugdenhil RJ; Bolhuis RL
    Int Immunol; 1990; 2(12):1213-20. PubMed ID: 1982501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function.
    Ferrini S; Cambiaggi A; Meazza R; Sforzini S; Marciano S; Mingari MC; Moretta L
    Eur J Immunol; 1994 Oct; 24(10):2294-8. PubMed ID: 7925558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The natural killer-related receptor for HLA-C expressed on T cells from CD3+ lymphoproliferative disease of granular lymphocytes displays either inhibitory or stimulatory function.
    Cambiaggi A; Orengo AM; Meazza R; Sforzini S; Tazzari PL; Lauria F; Raspadori D; Zambello R; Semenzato G; Moretta L; Ferrini S
    Blood; 1996 Mar; 87(6):2369-75. PubMed ID: 8630400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of the CD45 (T-200) molecule in anti-CD3-triggered T cell-mediated cytotoxicity.
    Deem RL; Shanahan F; Niederlehner A; Targan SR
    Cell Immunol; 1988 Nov; 117(1):99-110. PubMed ID: 2972397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of lysis by T cell receptor gamma delta+/CD3+ T lymphocytes via CD2 requires triggering via the T11.1 epitope only.
    Goedegebuure PS; Segal DM; Braakman E; Vreugdenhil RJ; Van Krimpen BA; Van de Griend RJ; Bolhuis RL
    J Immunol; 1989 Mar; 142(6):1797-802. PubMed ID: 2466076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Agonistic effects of anti-CD2 and anti-CD16 antibodies on human natural killer killing.
    Uggla CK; Geisberg M; Jondal M; Knowles RW
    Scand J Immunol; 1989 May; 29(5):507-15. PubMed ID: 2567053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of human cytolytic cells through CD2/T11. Comparison of the requirements for the induction and direction of lysis of tumor targets by T cells and NK cells.
    Scott CF; Bolender S; McIntyre GD; Holldack J; Lambert JM; Venkatesh YP; Morimoto C; Ritz J; Schlossman SF
    J Immunol; 1989 Jun; 142(11):4105-12. PubMed ID: 2565930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies to adhesion molecules inhibit the lytic function of MHC-unrestricted cytotoxic cells by preventing their activation.
    Zarcone D; Viale O; Cerruti G; Tenca C; Malorni W; Arancia G; Iosi F; Galandrini R; Velardi A; Moretta A
    Cell Immunol; 1992 Sep; 143(2):389-404. PubMed ID: 1380897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fc gamma RIII activation is different in CD16+ cytotoxic T lymphocytes and natural killer cells.
    Uciechowski P; Gessner JE; Schindler R; Schmidt RE
    Eur J Immunol; 1992 Jun; 22(6):1635-8. PubMed ID: 1376268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles.
    Moretta A; Vitale M; Sivori S; Bottino C; Morelli L; Augugliaro R; Barbaresi M; Pende D; Ciccone E; Lopez-Botet M; Moretta L
    J Exp Med; 1994 Aug; 180(2):545-55. PubMed ID: 8046333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural killer cells in rhesus monkeys: properties of effector cells which lyse Raji targets.
    Carver FM; Thomas JM
    Cell Immunol; 1988 Nov; 117(1):56-69. PubMed ID: 2902933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural killer lines and clones with apparent antigen specificity.
    Suzuki N; Bianchi E; Bass H; Suzuki T; Bender J; Pardi R; Brenner CA; Larrick JW; Engleman EG
    J Exp Med; 1990 Aug; 172(2):457-62. PubMed ID: 2142719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific recognition of human CD3-CD16+ natural killer cells requires the expression of an autosomic recessive gene on target cells.
    Ciccone E; Pende D; Viale O; Tambussi G; Ferrini S; Biassoni R; Longo A; Guardiola J; Moretta A; Moretta L
    J Exp Med; 1990 Jul; 172(1):47-52. PubMed ID: 1694227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.